AKT1 and neoplasm: The results from our Western blot analysis on the tumor tissue samples clearly showed that Akt signaling was pronouncedly suppressed in the tumors treated with paclitaxel/17-AAG-loaded micelles, even though the treatment was ended three weeks earlier.